Company
United StatesPhilip NMI Raskin, Dallas, TX – FDA Inspections
Inspection records and compliance data for Philip NMI Raskin in Dallas, Texas. 4 FDA inspections on record, 1 Form 483, last inspected January 11, 2024.
Company Profile
This profile covers Philip NMI Raskin based in Dallas, Texas, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 3
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected June 23, 2010. Last inspected January 11, 2024.
Most cited issue areas
- FD-1572, protocol compliance3 inspections
- Case history records- inadequate or inadequate1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 11, 2024 | VAI | Human Drugs · Bioresearch Monitoring | 1226830 |
| September 4, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1130798 |
| February 20, 2018 | VAI | Human Drugs · Bioresearch Monitoring | 1041550 |
| June 23, 2010 | VAI | Human Drugs · Bioresearch Monitoring | 671386 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Philip NMI Raskin
FEI Number
3008281994
Address
University Of Texas Southwestern, 5323 Harry Hines Blvd G52, Dallas, Texas 75390, United States
Country
United States
ID: 9074ba12-52ed-4918-8a4e-7fbcab7f7974